Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management
- PMID: 26907513
- PMCID: PMC4870649
- DOI: 10.1089/dia.2015.0324
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management
Abstract
Background: The MiniMed 640G sensor-augmented insulin pump system (Medtronic, Inc., Northridge, CA) can automatically suspend insulin delivery in advance of predicted hypoglycemia and restart it upon recovery. The aims of this analysis were to determine the rate at which predicted hypoglycemia was avoided with this strategy, as well as to assess user acceptance of the system and its insulin management features.
Subjects and methods: Forty subjects with type 1 diabetes used the system for 4 weeks. We retrospectively evaluated performance of the system, using downloaded pump and sensor data, and evaluated user acceptance via questionnaires.
Results: There were 2,322 suspend before low events (2.1 per subject-day). The mean (± SD) duration of pump suspension events was 56.4 ± 9.6 min, and the mean subsequent sensor glucose (SG) nadir was 71.8 ± 5.2 mg/dL. SG values following 1,930 (83.1%) of the predictive suspensions did not reach the preset low limit. Nadir SG values of ≤50 and ≤60 mg/dL were seen in 207 (8.9%) and 356 (15.3%) of the predictive suspensions, respectively. Blood glucose (BG) and SG values before and during the study were comparable (P > 0.05). The mean absolute relative difference between paired SG and BG values was 10.9 ± 13.8%. Subjects felt confident using the system, agreed that it helped protect them from hypoglycemia, and wished to continue using it.
Conclusions: Automatic insulin pump suspension as implemented in the MiniMed 640G system can help patients avoid hypoglycemia, without significantly increasing hyperglycemia.
Figures

Comment in
-
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708. JAMA. 2016. PMID: 27629148 No abstract available.
Similar articles
-
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.Diabetes Technol Ther. 2018 Nov;20(11):731-737. doi: 10.1089/dia.2018.0209. Epub 2018 Oct 6. Diabetes Technol Ther. 2018. PMID: 30299976
-
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.Diabetes Technol Ther. 2017 Mar;19(3):173-182. doi: 10.1089/dia.2016.0349. Epub 2017 Jan 18. Diabetes Technol Ther. 2017. PMID: 28099035 Free PMC article.
-
Evaluation of a Predictive Low-Glucose Management System In-Clinic.Diabetes Technol Ther. 2017 May;19(5):288-292. doi: 10.1089/dia.2016.0319. Epub 2017 Feb 16. Diabetes Technol Ther. 2017. PMID: 28221823
-
The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.Pediatr Diabetes. 2020 Nov;21(7):1256-1267. doi: 10.1111/pedi.13088. Epub 2020 Sep 14. Pediatr Diabetes. 2020. PMID: 32738022
-
Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.J Diabetes Sci Technol. 2017 Jan;11(1):50-58. doi: 10.1177/1932296816672689. Epub 2016 Oct 6. J Diabetes Sci Technol. 2017. PMID: 28264173 Free PMC article. Review.
Cited by
-
One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.Diabetes Care. 2019 Dec;42(12):2190-2196. doi: 10.2337/dc19-0855. Epub 2019 Sep 23. Diabetes Care. 2019. PMID: 31548247 Free PMC article.
-
Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes.Drugs Aging. 2022 Jan;39(1):23-37. doi: 10.1007/s40266-021-00900-3. Epub 2021 Oct 19. Drugs Aging. 2022. PMID: 34664212 Review.
-
Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy.Endocrinol Diabetes Metab Case Rep. 2017 Oct 28;2017:17-0093. doi: 10.1530/EDM-17-0093. eCollection 2017. Endocrinol Diabetes Metab Case Rep. 2017. PMID: 29118986 Free PMC article.
-
Effectiveness of Automated Insulin Management Features of the MiniMed® 640G Sensor-Augmented Insulin Pump.Diabetes Technol Ther. 2016 Oct;18(10):657-663. doi: 10.1089/dia.2016.0216. Epub 2016 Sep 27. Diabetes Technol Ther. 2016. PMID: 27672710 Free PMC article.
-
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD.Clin J Am Soc Nephrol. 2023 Jan 1;18(1):130-145. doi: 10.2215/CJN.04510422. Epub 2022 Sep 22. Clin J Am Soc Nephrol. 2023. PMID: 36719162 Free PMC article. Review.
References
-
- Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224–232 - PubMed
-
- Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW: Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013;310:1240–1247 - PubMed
-
- Danne T, Tsioli C, Kordonouri O, Blaesig S, Remus K, Roy A, Keenan B, Lee SW, Kaufman FR: The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Ther 2014;16:338–347 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical